---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-017505"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2022-08-16T23:59:59+00:00"
generated_at: "2026-06-23T23:24:35.147368+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio closes $13.8M underwritten public offering of common stock, Series B preferred, and warrants

## Summary
- Gross proceeds ~$13.8M; net proceeds ~$12.2M after underwriting discounts and estimated expenses.
- Issued 49.36M shares common, 1,460 shares Series B preferred (convertible into 4,000 common each), plus warrants for 55.2M shares at $0.25 exercise price.
- Underwriter's over-allotment option fully exercised for an additional 7.2M common shares and warrants.
- Warrants exercisable only after stockholder approval per Nasdaq rules; Series 1 expires in 1 year, Series 2 in 5 years.
- Post-offering outstanding common shares: 71,240,169 (excluding 5.84M shares from Series B conversion).

## SEC filing metadata
- accession: 0000950170-22-017505
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2022-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000095017022017505/0000950170-22-017505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000095017022017505/pali-20220812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-017505
- JSON: https://secwatch.observer/filing/0000950170-22-017505.json
- Plain text: https://secwatch.observer/filing/0000950170-22-017505.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.